These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 9389604

  • 1. The non-competitive AMPA antagonist LY 300168 (GYKI 53655) attenuates AMPA-induced hippocampal injury in neonatal rodents.
    Liu XH, Wang P, Barks JD.
    Neurosci Lett; 1997 Oct 10; 235(1-2):93-7. PubMed ID: 9389604
    [Abstract] [Full Text] [Related]

  • 2. gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats.
    Barks JD, Liu XH, Sun R, Silverstein FS.
    Neuroscience; 1997 Jan 10; 76(2):397-409. PubMed ID: 9015325
    [Abstract] [Full Text] [Related]

  • 3. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures.
    Kristensen BW, Noraberg J, Zimmer J.
    Brain Res; 2001 Oct 26; 917(1):21-44. PubMed ID: 11602227
    [Abstract] [Full Text] [Related]

  • 4. Tat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal rats.
    Wang P, Barks JD, Silverstein FS.
    Neuroscience; 1999 Jan 26; 88(2):585-97. PubMed ID: 10197777
    [Abstract] [Full Text] [Related]

  • 5. Stereoselective neuroprotection by novel 2,3-benzodiazepine non-competitive AMPA antagonist against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures.
    May PC, Robison PM, Fuson KS.
    Neurosci Lett; 1999 Mar 12; 262(3):219-21. PubMed ID: 10218895
    [Abstract] [Full Text] [Related]

  • 6. Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus.
    Moncada C, Arvin B, Le Peillet E, Meldrum BS.
    Neurosci Lett; 1991 Dec 09; 133(2):287-90. PubMed ID: 1816508
    [Abstract] [Full Text] [Related]

  • 7. Ethanol inhibition of synaptically evoked kainate responses in rat hippocampal CA3 pyramidal neurons.
    Weiner JL, Dunwiddie TV, Valenzuela CF.
    Mol Pharmacol; 1999 Jul 09; 56(1):85-90. PubMed ID: 10385687
    [Abstract] [Full Text] [Related]

  • 8. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    Willis CL, Meldrum BS, Nunn PB, Anderton BH, Leigh PN.
    Brain Res; 1993 Nov 05; 627(1):55-62. PubMed ID: 7507397
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
    Bespalov A, Dravolina O, Belozertseva I, Adamcio B, Zvartau E.
    Behav Pharmacol; 2006 Jun 05; 17(4):295-302. PubMed ID: 16914947
    [Abstract] [Full Text] [Related]

  • 12. In vivo, the direct and seizure-induced neuronal cytotoxicity of kainate and AMPA is modified by the non-competitive antagonist, GYKI 52466.
    Lees GJ, Leong W.
    Brain Res; 2001 Jan 26; 890(1):66-77. PubMed ID: 11164769
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neuroprotective effect of GYKI 52466 on AMPA-induced neurotoxicity in rat striatum.
    Bartha E, Lovas G, Szentkuty E, Horváth EJ, Palkovits M.
    Neurobiology (Bp); 1998 Jan 26; 6(2):127-39. PubMed ID: 9785349
    [Abstract] [Full Text] [Related]

  • 15. Exacerbation of NMDA, AMPA, and L-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate.
    Greene JG, Greenamyre JT.
    J Neurochem; 1995 May 26; 64(5):2332-8. PubMed ID: 7536810
    [Abstract] [Full Text] [Related]

  • 16. Effect of glutamate receptor antagonists on N-methyl-D-aspartate- and (S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced convulsant effects in mice and rats.
    Bisaga A, Krzascik P, Jankowska E, Palejko W, Kostowski W, Danysz W.
    Eur J Pharmacol; 1993 Oct 05; 242(3):213-20. PubMed ID: 7506658
    [Abstract] [Full Text] [Related]

  • 17. GYKI 52466 protects against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures.
    May PC, Robison PM.
    Neurosci Lett; 1993 Apr 02; 152(1-2):169-72. PubMed ID: 8100052
    [Abstract] [Full Text] [Related]

  • 18. D-aspartate and NMDA, but not L-aspartate, block AMPA receptors in rat hippocampal neurons.
    Gong XQ, Frandsen A, Lu WY, Wan Y, Zabek RL, Pickering DS, Bai D.
    Br J Pharmacol; 2005 Jun 02; 145(4):449-59. PubMed ID: 15806114
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.